These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2971114)

  • 1. Analysis of blood cell populations, plasma zinc and natural killer cell activity in young children with Down's syndrome.
    Noble RL; Warren RP
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():193-201. PubMed ID: 2971114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.
    Lockitch G; Singh VK; Puterman ML; Godolphin WJ; Sheps S; Tingle AJ; Wong F; Quigley G
    Pediatr Res; 1987 Nov; 22(5):536-40. PubMed ID: 2960948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the immune system in Down's syndrome patients].
    Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V
    Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21).
    Noble RL; Warren RP
    Immunol Invest; 1987 Aug; 16(5):371-82. PubMed ID: 2961683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients].
    Soto-Quintana M; Alvarez-Nava F; Rojas-Atencio A; Granadillo V; Fernández D; Ocando A; López E; Fulcado W
    Invest Clin; 2003 Mar; 44(1):51-60. PubMed ID: 12703183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.
    Gupta S; Fikrig SM; Mariano E; Quazi Q
    Clin Exp Immunol; 1983 Jul; 53(1):25-30. PubMed ID: 6223734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency.
    Licastro F; Mariani RA; Faldella G; Carpenè E; Guidicini G; Rangoni A; Grilli T; Bazzocchi G
    Brain Res Bull; 2001 May; 55(2):313-7. PubMed ID: 11470333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood zinc in patients with Down's syndrome and its relations with their immune status].
    Colombo ML; Givrardo E; Ricci BM; Maina D
    Minerva Pediatr; 1989 Feb; 41(2):71-5. PubMed ID: 2525662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation.
    Stabile A; Pesaresi MA; Stabile AM; Pastore M; Sopo SM; Ricci R; Celestini E; Segni G
    Clin Immunol Immunopathol; 1991 Feb; 58(2):207-16. PubMed ID: 1824686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.
    Nair MP; Schwartz SA
    Clin Immunol Immunopathol; 1984 Dec; 33(3):412-24. PubMed ID: 6209046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects.
    Franceschi C; Chiricolo M; Licastro F; Zannotti M; Masi M; Mocchegiani E; Fabris N
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():169-81. PubMed ID: 2971113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome.
    Cossarizza A; Ortolani C; Forti E; Montagnani G; Paganelli R; Zannotti M; Marini M; Monti D; Franceschi C
    Blood; 1991 Mar; 77(6):1263-70. PubMed ID: 1825795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters.
    Licastro F; Chiricolo M; Mocchegiani E; Fabris N; Zannoti M; Beltrandi E; Mancini R; Parente R; Arena G; Masi M
    J Intellect Disabil Res; 1994 Apr; 38 ( Pt 2)():149-62. PubMed ID: 8193451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocytes in patients with Down's syndrome.
    Wisniewski K; Cobill JM; Wilcox CB; Caspary EA; Williams DG; Wisniewski HM
    Biol Psychiatry; 1979 Jun; 14(3):463-71. PubMed ID: 157786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct abnormalities in the innate immune system of children with Down syndrome.
    Bloemers BL; van Bleek GM; Kimpen JL; Bont L
    J Pediatr; 2010 May; 156(5):804-9, 809.e1-809.e5. PubMed ID: 20172534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell activity and ultrastructure in myeloproliferative reactions in infants with Down's syndrome.
    Miale TD; Nasrallah AG; Lobel SA; Demian S; Bowman WP
    Am J Pediatr Hematol Oncol; 1986; 8(3):191-9. PubMed ID: 2945495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific and specific immune responses in a child with Down's syndrome and her sibling. A case report.
    Reuland-Bosma W; van den Barselaar MT; van de Gevel JS; Leijh PC; de Vries-Huiges H; The HT
    J Periodontol; 1988 Apr; 59(4):249-53. PubMed ID: 2968446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells.
    Chang WC; Fujimiya Y; Casteel N; Pattengale P
    Int J Cancer; 1989 Apr; 43(4):591-7. PubMed ID: 2522912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.